Zanetta S. Lamar, MD

Assistant Professor, Hematology and Oncology

Zanetta S. Lamar, MD

Assistant Professor, Hematology and Oncology

About Me

Education: BS, Grambling State University, 2003; MD, Meharry Medical College, 2007
Residency: Internal Medicine, North Carolina Baptist Hospital, 2010
Fellowship: Hematology And Oncology, Wake Forest University School of Medicine, 2013
Board Certifications: American Board of Internal Medicine, Hematology; American Board of Internal Medicine, Internal Medicine; American Board of Internal Medicine, Medical Oncology
Positions: Assistant Professor, Hematology and Oncology
Departments and Affiliations: Hematology and Oncology; Center for Redox Research in Biology and Medicine

Research

Publications
Clinical Trials

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M, . Lancet Oncol. 2018 Sep; 19(9):1192-1204.
Left Ventricular Mass Change After Anthracycline Chemotherapy. Jordan JH, Castellino SM, Meléndez GC, Klepin HD, Ellis LR, Lamar Z, Vasu S, Kitzman DW, Ntim WO, Brubaker PH, Reichek N, D'Agostino RB, Hundley WG. Circ Heart Fail. 2018 Jul; 11(7):e004560.
Endobronchial Ultrasound Transbronchial Needle Aspiration for the Diagnosis of Lymphoma. Gandotra S, Dotson T, Lamar Z, Bellinger C. J Bronchology Interv Pulmonol. 2018 Apr; 25(2):97-102.
A human bone marrow mesodermal-derived cell population with hemogenic potential. Mokhtari S, Colletti E, Yin W, Sanada C, Lamar Z, Simmons PJ, Walker S, Bishop C, Atala A, Zanjani ED, Porada CD, Almeida-Porada G. Leukemia. 2018 07; 32(7):1575-1586.
Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study. Lamar ZS, Dothard A, Kennedy L, Isom S, Robinson M, Vaidya R, Hurd D, McClain D, Lesser G. Leuk. Lymphoma. 2018 08; 59(8):1871-1877.

View More Publications

Study of an experimental drug for T-Cell Non-Hodgkin or Classic Hodgkin Lymphoma

More Resources

More Resources

Zanetta S. Lamar, MD

Zanetta S. Lamar, MD

About Me